Fact based stock research
MediPal Holdings (TSE:7459)

JP3268950007

MediPal Holdings stock research in summary

medipal.co.jp


MediPal Holdings shares are less expensive than other comparable stocks. They are safely financed and are good value, but show below average growth. We recommend evaluating whether the future of the company MediPal Holdings is really as difficult as the low price of the stock suggests. If you believe that the future of the company is market-typical or even better, then this could be an argument for a share purchase.


Latest Obermatt Ranks


Value Rank 88
Growth Rank 44
Safety Rank 91
Combined Rank 100
Country Japan
Industry Health Care Distributors
Index
Size class XX-Large

September 15, 2022. Stock data may be delayed. Login to get the most recent research.

Add to Watchlist
Filter Similar Stocks
Similar Top 10

Research History: MediPal Holdings

RESEARCH HISTORY 2019 2020 2021 2022
VALUE
VALUE n/a
98
100
88
GROWTH
GROWTH n/a
42
22
44
SAFETY
SAFETY n/a
83
84
91
COMBINED
COMBINED n/a
100
97
100

Last update of Combined Rank: 15-Sep-2022. Financial reporting date used for calculating ranks: 30-Jun-2022. Stock research history is based on the Obermatt Method. The higher the rank, the better MediPal Holdings is in the corresponding investment strategy.


Value Metrics in Detail

VALUE METRICS 2019 2020 2021 2022
PRICE VS. REVENUES (P/S)
PRICE VS. REVENUES (P/S) n/a
98
96
98
PRICE VS. PROFITS (P/E)
PRICE VS. PROFITS (P/E) n/a
87
77
67
PRICE VS. CAPITAL (Market-to-Book)
PRICE VS. CAPITAL (Market-to-Book) n/a
90
96
92
DIVIDEND YIELD
DIVIDEND YIELD n/a
56
54
78
CONSOLIDATED RANK: VALUE
CONSOLIDATED RANK: VALUE n/a
98
100
88

Last update of Value Rank: 15-Sep-2022. Stock analysis on value ratios: The higher the rank, the lower the value ratio of MediPal Holdings; except for dividend yield where the rank is higher, the higher the yield.


Growth Metrics in Detail

GROWTH METRICS 2019 2020 2021 2022
REVENUE GROWTH
REVENUE GROWTH n/a
50
6
29
PROFIT GROWTH
PROFIT GROWTH n/a
56
75
57
STOCK RETURNS
STOCK RETURNS n/a
32
51
46
CONSOLIDATED RANK: GROWTH
CONSOLIDATED RANK: GROWTH n/a
42
22
44

Last update of Growth Rank: 30-Jun-2022. Stock analysis on growth metrics: The higher the rank, the higher the growth and returns of MediPal Holdings.


Safety Metrics in Detail

SAFETY METRICS 2019 2020 2021 2022
LEVERAGE
LEVERAGE n/a
96
98
98
REFINANCING
REFINANCING n/a
20
18
26
LIQUIDITY
LIQUIDITY n/a
100
100
97
CONSOLIDATED RANK: SAFETY
CONSOLIDATED RANK: SAFETY n/a
83
84
91

Last update of Safety Rank: 9-Sep-2022. Stock analysis on safety metrics: The higher the rank, the lower the leverage of MediPal Holdings and the more cash is available to service its debt.


Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for MediPal Holdings from September 15, 2022.


We invest in our stock tips ourselves and openly publish the returns of our portfolio. That's how much we believe in our stock research. Subscribe to the top 10 stocks for 100 markets conveniently by e-mail.